1st Quarter - Report
ALEXION PHARMACEUTICALS, INC. for ALEXION PHARMACEUTICALS, INC.
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to Medicare Part B; Inpatient Hospital Reimbursement; Medicare Part D patient affordability; Medicaid; ERISA
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIGH OWANO | — |
| VANESSA PROCTER | — |
Health Issues HCR
Issues related to Orphan Drug Act; Drug Pricing; IPI Model
| Lobbyist | Covered position, as disclosed |
|---|---|
| LEIGH OWANO | — |
| VANESSA PROCTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.